Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PennantPark Investment Corp. | 1 | 0 | 0 | 0 | €6.35 | €10.00 | 57.431% |
| Sixt SE VZO | 3 | 0 | 1 | 0 | €51.50 | - | - |
| Re/Max Holdings Inc | 1 | 0 | 0 | 0 | €7.60 | €10.00 | 31.579% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €9.09 | €26.25 | 188.611% |
| NFON AG | 2 | 0 | 0 | 0 | €6.00 | €8.00 | 33.333% |
| KBR Inc. | 17 | 0 | 1 | 0 | €59.00 | €71.65 | 21.439% |
| Alkermes plc | 17 | 2 | 3 | 0 | €24.00 | €35.01 | 45.888% |
| Hoeegh Autoliners Asa | 4 | 0 | 0 | 0 | €9.95 | €15.00 | 50.754% |
| L3Harris Technologies Inc. | 28 | 0 | 4 | 0 | €209.10 | €220.24 | 5.326% |
| Accenture plc A | 28 | 0 | 1 | 0 | €289.30 | €345.46 | 19.414% |
| Financiere Odet | 1 | 0 | 0 | 0 | €1,420.0 | €1,500.0 | 5.634% |
| Cimpress plc | 2 | 0 | 0 | 0 | €76.00 | - | - |
| Personalis Inc | 8 | 1 | 0 | 0 | €2.98 | €3.26 | 9.477% |
| Celldex Therapeutics | 18 | 1 | 3 | 0 | €30.00 | €62.02 | 106.717% |
| iShares MSCI World Value Factor UCITS ETF | 1 | 0 | 0 | 0 | €37.96 | - | - |
| BGSF Inc. | 2 | 0 | 0 | 0 | €7.80 | - | - |
| Under Armour Inc. A | 1 | 1 | 0 | 0 | €7.23 | €8.38 | 15.864% |
| MasterCraft Boat Holdings Inc. | 6 | 0 | 1 | 0 | €17.40 | €23.21 | 33.376% |
| Ladder Capital Corp | 6 | 0 | 3 | 0 | €10.70 | €12.08 | 12.912% |
| Summit Materials Inc. | 14 | 0 | 4 | 0 | €33.60 | €43.04 | 28.089% |
| Eaton Corp. | 17 | 2 | 2 | 0 | €267.10 | €308.81 | 15.614% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €85.98 | - | - |
| O-I Glass Inc. | 12 | 0 | 3 | 0 | €9.85 | €19.04 | 93.324% |
| UMB Financial Corp | 11 | 1 | 3 | 0 | €86.00 | €93.22 | 8.395% |
| Kinross Gold Corp. | 10 | 2 | 0 | 0 | €7.76 | €8.78 | 13.163% |